Last updated: February 15, 2023
Sponsor: Fundacion CITA-alzheimer
Overall Status: Active - Enrolling
Phase
N/A
Condition
Memory Loss
Mental Disability
Mild Cognitive Impairment
Treatment
N/AClinical Study ID
NCT04840030
Go-on_studyprotocol_v3_apr20
Ages 60-85 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- People between 60-85 years old, willing to participate and comply with all the studyevaluation and intervention procedures.
- With a CAIDE dementia Risk score ≥ 6
- Below-than-expected cognitive performance in at least one of three brief cognitivetests:
- Fototest score ≤ 35
- Memory Alteration Test -T@M score ≤40
- Cognitive complaints as compared with a previous subjective performance - definedby a Cognitive Change Index - self-report version score >=20 on the first 12 (episodic memory) items to assist with defining Subjective Cognitive Decline (SCD) (Risacher et al. 2017).
Exclusion
Exclusion Criteria: Exclusion criteria are conditions that may affect the achievement of study objectives andprocedures or clinical diagnoses that by themselves compromise participant's cognitiveperformance or compliance with study procedures. They include:
- Inability to perform a neuropsychological evaluation or a cognitive stimulationprogram (sensory limitation, mental retardation, illiteracy)
- Barthel index < 90.
- Geriatric Depression Scale ≥ 9
- Dementia or Moderate Cognitive impairment (MMSE < 20).
- Presence of any neurological, psychiatric or systemic disease that produce cognitiveimpairment or dementia including, but not limited to, Huntington's disease, multiplesclerosis, Parkinson's disease, Down syndrome, alcohol abuse or active drugs, or majorpsychiatric disorders including ongoing major depression, schizophrenia or bipolar orschizoaffective disorder.
- Unstable ischemic cardiopathy, uncontrolled heart arrhythmia, thromboembolic diseasein the last year. Moderate cardiorespiratory insufficiency (including Class III or IVcongestive heart failure, clinically significant aortic stenosis, cardiac arresthistory, or uncontrolled angina). Currently receiving physical therapy orcardiopulmonary rehabilitation.
- Large vessel stroke in the past two years
- History of transient ischemia attack (TIA) or small vessel stroke in the last 6 months
- Any cerebrovascular accident with significant residual effects on cognition orfunctional autonomy.
- History within the last 2 years of treatment for primary or recurrent malignantdisease, excluding non-melanoma skin cancers, resected cutaneous squamous cellcarcinoma in situ, basal cell carcinoma, cervical carcinoma in situ, or situ prostatecancer with normal prostate-specific antigen posttreatment
- Recent (< 3 months) bone fracture.
- History of hip fracture, joint replacement, or spinal surgery in the last 6 months
- Clinically significant abnormalities in laboratory blood tests as per judgment of thesite Study Clinician
- Any conditions affecting safe engagement in the intervention in the judge of the studyinvestigators.
Study Design
Total Participants: 1094
Study Start date:
December 03, 2021
Estimated Completion Date:
September 30, 2026
Connect with a study center
CITA-alzheimer
Donostia-San Sebastián, Gipuzkoa 20009
SpainSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.